Andere talen Generation Bio Co.

Aandelen

GBIO

US37148K1007

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 21-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,75 ^USD	+4,17%		+0,36%	+66,67%

13/05	Generation Bio Co. Rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
09/05	Generation Bio Co. Kondigt de presentatie aan van preklinische gegevens over iqDNA- en ctLNP-platformen op de 27ste jaarlijkse ASGCT-bijeenkomst	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit	14/06
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results	13/05
Generation Bio Co. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting	09/05
Generation Bio Co. Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms At the ASGCT 27th Annual Meeting	09/05
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting	22/04
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference	02/04
Generation Bio Co. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results	06/03
Generation Bio Co. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/03
Generation Bio to Present at the 2024 TD Cowen Health Care Conference	27/02
Generation Bio to Present at the 2024 TD Cowen Health Care Conference	27/02
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01
Generation Bio Co.(NasdaqGS:GBIO) dropped from NASDAQ Biotechnology Index	15/12
Generation Bio Insider Bought Shares Worth $124,778, According to a Recent SEC Filing	05/12
Generation Bio to Lay Off 40% of Staff in Bid to Extend Cash Runway Into H2 2027	29/11
Generation Bio Co. Announces Termination of Executives, Effective on January 28, 2024	29/11
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms	29/11
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms	29/11
Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Generation Bio Co.

Aandelen

GBIO

US37148K1007

Andere talen

Filters